Vivos Therapeutics, Inc. Quarterly Long-term Debt and Lease Obligation in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Vivos Therapeutics, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q2 2023 to Q3 2024.
  • Vivos Therapeutics, Inc. Long-term Debt and Lease Obligation for the quarter ending September 30, 2024 was $1.2M, unchanged year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.2M $0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.2M $0 0% Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $1.2M Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $1.2M Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.2M Jun 30, 2023 10-Q 2023-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.